← Back
NeuroTrials.ai
Neurology Clinical Trial Database

Ipsilesional Arm Remediation

Targeted Remediation of the Ipsilesional Arm in Chronic Stroke: A Randomized Clinical Trial

Year of Publication: 2026

Authors: Maenza C, Winstein CJ, Murphy TE, ..., Sainburg RL

Journal: JAMA Neurology

Citation: Maenza C et al. JAMA Neurol. 2026;83(3):223-230. DOI: 10.1001/jamaneurol.2025.5496

Link: https://doi.org/10.1001/jamaneurol.2025.5496


Clinical Question

Does targeted training of the ipsilesional (less impaired) arm improve motor performance in chronic stroke patients with severe contralesional arm paresis?

Bottom Line

Targeted ipsilesional arm training with virtual reality and manipulation significantly improved ipsilesional hand function (12% faster on JTHFT, p=0.003) in chronic stroke patients with severe hemiparesis, with benefits sustained at 6 months. This identifies the ipsilesional arm as an important and modifiable rehabilitation target.

Major Points

  • First RCT demonstrating that ipsilesional arm motor deficits are modifiable even years after stroke
  • Significant improvement in Jebsen-Taylor Hand Function Test: −5.87 seconds (95% CI −8.89 to −2.85, P=0.003), representing a 12% reduction in completion time
  • Improvements sustained at both 3-week and 6-month follow-up in the ipsilesional training group only
  • No improvement in functional independence (Barthel), contralesional impairment (Fugl-Meyer), or perceived manual ability (ABILHAND-Stroke)
  • Supports the ipsilesional arm as an underrecognized rehabilitation target for patients with severe hemiparesis who depend on that limb for daily independence

Design

Study Type: Two-site, parallel-group, randomized clinical trial with blinded outcome assessment

Randomization: 1

Blinding: Blinded outcome assessment (assessor-blinded)

Enrollment Period: February 2019 to August 2024

Follow-up Duration: 6 months post-treatment

Centers: 2

Countries: USA

Sample Size: 53

Analysis: Modified intention-to-treat


Inclusion Criteria

  • Adults with radiologically confirmed unilateral middle cerebral artery stroke
  • Chronic phase (>6 months post-stroke implied by study design)
  • Severe contralesional upper-extremity impairment (Fugl-Meyer score ≤28)
  • Ipsilesional motor deficits present

Arms

FieldIpsilesional Arm TrainingControl
n2528
Intervention5-week, 15-session ipsilesional virtual reality and manipulation trainingDose-matched, best practice contralesional arm therapy
Duration5 weeks5 weeks

Outcomes

OutcomeTypeControlInterventionHR / OR / RRP-value
Jebsen-Taylor Hand Function Test (excluding writing) — ipsilesional motor performancePrimaryNo significant improvementSignificant improvement0.003
Barthel Index (functional independence)Secondary
Fugl-Meyer Assessment Upper Extremity (contralesional impairment)Secondary
ABILHAND-Stroke (perceived manual ability)Secondary

Criticisms

  • Small sample size (n=53) limits generalizability
  • Only 2 sites in the USA
  • No improvement in functional independence or patient-reported outcomes despite motor performance gains
  • Assessor-blinded but not participant- or therapist-blinded, which may introduce performance bias
  • Specific to patients with severe hemiparesis (Fugl-Meyer ≤28) — findings may not generalize to mild/moderate deficits

Funding

US National Institutes of Health (NIH)

Based on: Ipsilesional Arm Remediation (JAMA Neurology, 2026)

Authors: Maenza C, Winstein CJ, Murphy TE, ..., Sainburg RL

Citation: Maenza C et al. JAMA Neurol. 2026;83(3):223-230. DOI: 10.1001/jamaneurol.2025.5496

Content summarized and formatted by NeuroTrials.ai.